Written by Judit Rius Sanjuan
The most important international intellectual property agreement regulating remedies for intellectual property infringement is the 1994 WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (the TRIPS Agreement).
Continue Reading →
What Are Counterfeit Medicines?
The definition of a counterfeit medicine is not well established. In 1992, the WHO defined a counterfeit medicine as: “a medicine which is deliberately and fraudulently mislabelled with respect to identity and/or source." Under this definition, it is the deliberate mislabeling of a drug or medicine which makes it a counterfeit. The US FDA uses a similar definition,
Continue Reading →
To provide some context to discussions on the term of protection for copyright and related rights, the following note sumarizes on the basic provisions in various multilateral copyright and related rights treaties, on the topics of minimum terms and formalities. … Continue Reading →
Written by James Love
Wednesday, 07 January 2009
Program and Agenda
(Draft 7Jan09)
Roundtable on De-linking R&D Incentives from Prices
Designing Innovation Inducement Prizes for Diagnostics, New Drugs and Vaccines for Type II and III diseases and conditions, with a particular focus on TB and Chagas Disease
Continue Reading →
Sunday, 29 April 2007
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.
Continue Reading →